UBS ASSET MANAGEMENT AMERICAS LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 126 filers reported holding FATE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$75,065
-62.8%
35,4080.0%0.00%
Q2 2023$201,8270.0%35,4080.0%0.00%
Q1 2023$201,827
-74.4%
35,408
-54.7%
0.00%
Q4 2022$788,544
-100.0%
78,151
-81.0%
0.00%
-100.0%
Q3 2022$9,208,111,000
-27.7%
410,893
-20.1%
0.01%
-28.6%
Q2 2022$12,739,325,000
-26.0%
514,097
+15.8%
0.01%0.0%
Q1 2022$17,215,818,000
-31.1%
444,050
+3.9%
0.01%
-30.0%
Q4 2021$25,003,838,000
+17.4%
427,343
+18.9%
0.01%
+11.1%
Q3 2021$21,302,173,000
-28.6%
359,409
+4.6%
0.01%
-30.8%
Q2 2021$29,818,181,000
+20.7%
343,567
+14.7%
0.01%
+18.2%
Q1 2021$24,701,442,000
-33.8%
299,593
-27.0%
0.01%
-35.3%
Q4 2020$37,319,945,000
+64.5%
410,425
-27.7%
0.02%
+41.7%
Q3 2020$22,684,414,000
+18.7%
567,536
+1.9%
0.01%0.0%
Q2 2020$19,113,208,000
+134.8%
557,074
+52.0%
0.01%
+100.0%
Q1 2020$8,141,231,000
-24.6%
366,557
-33.5%
0.01%
-14.3%
Q4 2019$10,792,777,000
+26.1%
551,496
+0.0%
0.01%
+16.7%
Q3 2019$8,561,317,000
-21.7%
551,276
+2.3%
0.01%
-25.0%
Q2 2019$10,940,299,000
+17.1%
538,931
+1.4%
0.01%
+14.3%
Q1 2019$9,341,986,000
+41.8%
531,701
+3.5%
0.01%
+16.7%
Q4 2018$6,588,257,000
+514.8%
513,504
+680.7%
0.01%
+500.0%
Q3 2018$1,071,524,00065,7780.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders